Marwan Nasif, MD
-
Specialty: Cardiology
View Expertise -
Primary Location: 7580 Auburn Rd (22 mi.)
Other Locations - Languages Spoken: English, Arabic, Spanish
Office Locations
UH TriPoint Physician Pavilion (22 mi.)
7580 Auburn Rd
Ste 214
Concord, OH 44077
440-354-0944
UH Lake West Physician Pavillion (12 mi.)
36060 Euclid Ave
Ste 204
Willoughby, OH 44094
440-354-0944
Biography: Marwan Nasif, MD
Expertise
Certifications & Memberships
- Advanced Heart Failure and Transplant Cardiology - American Board of Internal Medicine
- Interventional Cardiology - American Board of Internal Medicine
- Cardiovascular Disease - American Board of Internal Medicine
Education
Fellowship | Interventional Cardiology
Interventional Cardiology - Tulane University Hospital And Clinic (2015 - 2016)
Fellowship | Cardiology
Cardiology - UH Case Medical Center (2012 - 2015)
Fellowship | Heart Failure
Heart Failure - Uh Case Medical Center (2010 - 2011)
Residency | Internal Medicine
Internal Medicine - Beaumont Health System, Royal Oak (2004 - 2007)
Other Education
Case Western Reserve University (2010)
Medical Education
Universitat De Valencia, Facultad De Medicina (2000)
About
Marwan G. Nasif, MD, is a general and interventional cardiologist at University Hospitals Harrington Heart & Vascular Institute. He is triple board certified in cardiovascular disease, interventional cardiology, and advanced heart failure and transplant cardiology.
Dr. Nasif earned his medical degree from the University of Valencia Faculty of Medicine in Valencia, Spain. His postdoctoral training included a residency in internal medicine at Beaumont Health System in Royal Oak, Michigan, followed by cardiology and heart failure fellowships at University Hospitals Case Medical Center (now University Hospitals Cleveland Medical Center.) He then completed an interventional cardiology fellowship at Tulane University Hospitals and Clinic in New Orleans, Louisiana.
With nearly 25 years of experience in the medical field, Dr. Nasif specializes in the diagnosis and treatment of the full span of common and complex heart conditions, including genetic heart defects, chronic high blood pressure, coronary artery disease, heart valve disorders, heart rhythm disorders, cardiomyopathies and congestive heart failure.
Dr. Nasif has co-authored publications in peer-reviewed medical journals such as the Journal of Interventional Cardiology and Catheter & Cardiovascular Interventions on interventional cardiovascular techniques for patients with heart failure.
Patient Experience Reviews
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Marwan Nasif did not disclose any Outside Relationships with Industry.